ALB and breast cancer: Zheng et al. shown that combined preoperative fibrinogen-albumin ratio and platelet-lymphocyte ratio score (FAR-PLR score) was a potential new biomarker for predicting survival and prognosis of breast cancer, and may facilitate better clinical decision making for breast cancer treatment by the physicians (34).